Posted 30th April 2018 by Jane Williams
Industrial and “omic” scale mutational profiling of solid tumours are possible as a result of massively parallel sequencing technology. However, these clinical genomic testing capabilities have also brought myriad new biological, technical and operational challenges not encountered in monogenic disorder testing. All of this impacts the interpretation and reporting of somatic variants. As a testament to the nascency of this field, the first published consensus guidelines for interpretation of variants in cancer was only released in early 2017.
Posted 11th April 2018 by Jane Williams
A stroke is a clinical condition that could benefit greatly from personalized medicine. Strokes remain a leading cause of mortality and morbidity in the United States, affecting over 800,000 adults annually, leaving many with a permanent disability. The current stroke population are approximately 195,000 recurrent strokes, which are often more severe, debilitating, and costly than first-time strokes.
Posted 23rd March 2018 by Jane Williams
The current field of cancer research is seeing gains in almost every aspect of care, from the foundations of the disease to the development of successful treatment. With increased funding and attention to oncology care, immunotherapy and precision medicine are among the most promising patient-centred areas of current research and translational medicine.
Posted 28th February 2018 by Jane Williams
7% of the population will be affected by a rare disease at some point in their lives. In anticipation of the Precision Medicine & Biomarkers Leaders Summit: USA and in recognition of Rare Disease Day, we have collated some of the top articles on rare diseases and their treatments.
Posted 14th February 2018 by Jane Williams
It was a pleasure to welcome back Miro Venturi to the Global Precision & Biomarkers Leaders Summit, our keynote speaker who spoke on the future of personalised medicine and the interplay of diseases, information and technologies. After his presentation, we sat down with him to get more of an insight into his thoughts on the future.
Posted 17th November 2017 by Jane Williams
Pathology Departments today are faced with many challenges in regards to effectively handling their workflow. More pathologists and technologists are retiring, while demand for specialist pathologists is increasing. Hospital laboratories are being forced to consolidate services and are seeking tools that can help them effectively provide more services without impacting on patient treatment.
Posted 20th October 2017 by Jane Williams
There has been a steady increase in the adoption of Quantitative Image Analysis (QIA) for diagnostic purposes, especially for breast biomarker testing.